The IARS recently announced the appointment of Lena S. Sun, MD, as the Medical Director of SmartTots. Dr. Sun is an established basic science, translational and clinical researcher, a board-certified physician in Pediatrics, Anesthesiology and Pediatric Anesthesiology and a practicing pediatric anesthesiologist. As the Medical Director of SmartTots, she will help promote and advocate for research to advance and ensure safety of anesthesia in children. She will specifically work with researchers, clinicians, parents and other relevant stakeholders to develop future research strategies to address the pressing challenges to understand the effects of anesthetic and sedative agents in the developing brain. She will also work with all stakeholders to support the implementation and dissemination of research results related to all SmartTots-related issues.
- Cell cycle activation contributes to isoflurane-induced neurotoxicity in the developing brain and the protective effect of CR8.
- Protective Effects of Xenon on Propofol-Induced Neurotoxicity in Human Neural Stem Cell-Derived Models.
- Neonatal exposure to propofol affects interneuron development in the piriform cortex and causes neurobehavioral deficits in adult mice.
- The expression of glucose transporters and mitochondrial division and fusion proteins in rats exposed to hypoxic preconditioning to attenuate propofol neurotoxicity.
- Inhibition of microRNA-375 ameliorated ketamine-induced neurotoxicity in human embryonic stem cell derived neurons.